Parenteral Nutrition Market Worth USD 8.36 Bn By 2026 | CAGR at 5.9%

Parenteral Nutrition

The “Parenteral Nutrition Market (By Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 – 2026” report has been added to Acumen Research and Consulting’s offers.
The global parenteral nutrition market size is estimated to reach USD 8.36 billion by 2026. The market is estimated to grow at a CAGR of 5.9% over the forecast period 2018-2026.
Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1282
Parenteral nutrition (PN) products are made by pro-pharmaceutical exacerbating organizations and are viewed as the most astounding danger of pharmaceutical planning accessible as the items can’t experience any type of terminal cleansing. The individual gets very perplexing nutritional formulae that contain supplements, for example, glucose, salts, amino acids, lipids, and included nutrients and dietary minerals. It is called total nutrient admixture (TNA) or total parenteral nutrition (TPN) when no critical nutrition is acquired by different courses, and partial parenteral nutrition (PPN) when nutrition is additionally halfway enteric. It might be called PPN when controlled through vein access in an appendage as opposed to through a focal vein as central venous nutrition (CVN).
Furthermore, ceaseless growth in birth rates and untimely births will likewise additionally bolster the growth of this market. Developing mindfulness about parenteral nutrition through government and non-benefit directs has permitted growth sought after for clinical nutrition in the worldwide patient populace, and therefore parenteral nutrition items.
The rising pervasiveness of incessant maladies, for example, diabetes in a previous couple of years and expanding patterns of malnutrition over the globe fundamentally drive the interest for different parenteral nutrition items around the world. Moreover, developing birth rates and expanded rate of untimely births should increase market request during projection years.
The high pervasiveness of incessant condition, for example, the disease is relied upon to advance the utilization of parenteral nutrition through chemotherapy sessions since this treatment mode prompts basic loss of nutrition, hunger, and vitality. Parenteral nutrition proficiently addresses these issues in chemotherapy patients and patients with other constant conditions where oral nutrition is unimaginable or isn’t adequate. Parenteral nutrition successfully beats the danger of dietary awkwardness in this manner adding to growth in its interest. Notwithstanding, being an intrusive procedure, dangers of contamination during organization and announcing of such occasions may keep down the growth of this market to a minor degree.
The global parenteral nutrition market is segmented into nutrient type and region. On the basis of nutrient type, the global market is segmented into carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins & minerals. On the basis of geography, the global market is segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.
The U.S. market is assessed to develop at a CAGR of 3.3 percent over the gauge time frame. The U.S. speaks to a noteworthy provincial market share pursued by Canada. The locale will observer a rewarding growth because of developing human services costs combined with an expansion in mindfulness among the populace about parenteral nutrition items and the rising pervasiveness of heart sicknesses. Improving social insurance framework, creating and extending the medical clinic area, and nearness of real industry players, for example, B. Braun with quickly extending business driven by universal pediatric nutritionists will increment local market share. In this way, the previously mentioned reasons will fuel parenteral nutrition market growth. The high pervasiveness of unending kidney issue in exceedingly populated nations, for example, China and India, quick improvement in social insurance foundation, increment in access to medicinal services offices and ascend in per capita human services consumption in the area are probably going to fuel the market in the Asia Pacific during the conjecture time frame. The extensive base of pharmaceutical organizations in nations, for example, India, Japan, and China likewise drive the market in the locale. Developing economies and extension of pharmaceutical markets in nations, for example, China, India, Indonesia, Singapore, Taiwan, and Thailand are relied upon to impel the market in the Asia Pacific. Rising instances of preterm birth, which prompts malnutrition, is a key reason fuelling the utilization of parenteral nutrition in the Asia Pacific.
Major companies contributing the global parenteral nutrition market are Actavis, Inc., Aculife (Nirlife), Baxter International, Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Grifols International S.A., Otsuka Pharmaceutical Factory, Inc., Sichuan Kelun Pharmaceutical Co. Ltd., and Vifor Pharma.
Browse All official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Parenteral Nutrition
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Parenteral Nutrition Market By Nutrient Type
1.2.2.1. Global Parenteral Nutrition Market Revenue and Growth Rate Comparison By Nutrient Type (2015-2026)
1.2.2.2. Global Parenteral Nutrition Market Revenue Share By Nutrient Type in 2017
1.2.2.3. Carbohydrates
1.2.2.4. Parenteral Lipid Emulsion
1.2.2.5. Single Dose Amino Acid Solution
1.2.2.6. Trace Elements
1.2.2.7. Vitamins & Minerals
1.2.2.8. Others
1.2.3. Parenteral Nutrition Market by Geography
1.2.3.1. Global Parenteral Nutrition Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Parenteral Nutrition Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Parenteral Nutrition Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Parenteral Nutrition Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Parenteral Nutrition Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Parenteral Nutrition Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Parenteral Nutrition Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Parenteral Nutrition Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Parenteral Nutrition Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Parenteral Nutrition Major Manufacturers in 2017
CHAPTER 4. PARENTERAL NUTRITION MARKET BY NUTRIENT TYPE
4.1. Global Parenteral Nutrition Revenue By Nutrient Type
4.2. Carbohydrates
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Parenteral Lipid Emulsion
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Single Dose Amino Acid Solution
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Trace Elements
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Vitamins & Minerals
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 5. NORTH AMERICA PARENTERAL NUTRITION MARKET BY COUNTRY
5.1. North America Parenteral Nutrition Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2. North America Parenteral Nutrition Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Parenteral Nutrition Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
CHAPTER 6. EUROPE PARENTERAL NUTRITION MARKET BY COUNTRY
6.1. Europe Parenteral Nutrition Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. Europe Parenteral Nutrition Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
CHAPTER 7. ASIA-PACIFIC PARENTERAL NUTRITION MARKET BY COUNTRY
7.1. Asia-Pacific Parenteral Nutrition Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Asia-Pacific Parenteral Nutrition Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
CHAPTER 8. LATIN AMERICA PARENTERAL NUTRITION MARKET BY COUNTRY 
8.1. Latin America Parenteral Nutrition Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Latin America Parenteral Nutrition Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
CHAPTER 9. MIDDLE EAST PARENTERAL NUTRITION MARKET BY COUNTRY 
9.1. Middle East Parenteral Nutrition Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Middle East Parenteral Nutrition Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
CHAPTER 10. AFRICA PARENTERAL NUTRITION MARKET BY COUNTRY 
10.1. Africa Parenteral Nutrition Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Africa Parenteral Nutrition Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Nutrient Type, 2015 – 2026 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. Nexans
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. ABB
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. General Cable
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. JDR
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Prysmian Group
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Parker Scanrope
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. NSW
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. LS Cable & System
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. NKT
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Others
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
The report is readily available and can be dispatched immediately after payment confirmation.
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

Post a Comment

0 Comments